Cargando…

Computational investigation into Nirematrelvir/Ritonavir synergetic efficiency compared with some approved antiviral drugs targeting main protease (M(pro)) SARS-CoV-2 Omicron variant

Although the severity of the spread of corona virus has recently decreased. On this day, there is no available effective medication established to treat COVID-19. Combination drug therapy has been recently gained new momentum as an important platform to design and develop several anti-infective agen...

Descripción completa

Detalles Bibliográficos
Autores principales: Makhloufi, Abdesselam, Ghemit, Rima, El Kolli, Meriem, Baitiche, Milad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Indian Chemical Society. Published by Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850841/
http://dx.doi.org/10.1016/j.jics.2023.100891